Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | N-(1-{[5-Carbamimidamido-1-hydroxy-2-(4-nitroanilino)pentylidene]amino}-1-oxo-3-phenylpropan-2-yl)pyrrolidine-2-carboximidic acid | HCID 123687 | — |
| Solvent | Tromethamine hydrochloride | HCID 93573 | — |
| Product | 4-Nitroaniline | HCID 7475 | — |
Reaction Steps
An inhibitor sample is dissolved in a 0.05 M Tris-hydrochloric acid buffer solution (pH=7.8) to make the total volume to 400 μl. To this solution, 50 μl of a 2 mM S-2302 solution is added and the mixture is incubated at a temperature of 37° C. for 5 minutes in a constant temperature bath. Then, 50 μl of a 0.12 unit/ml human plasma kallikrein is added and the mixture is incubated at a temperature of 37° C. for 5 minutes. Thereafter, 50 μl of 50% acetic acid is added to terminate the reaction. The absorbance of the p-nitroaniline formed in the reaction mixture is measured at 405 nm. Thus, the concentration I50 (μmol) of the inhibitor sample, at which the absorbance is one half (i.e., 1/2) of that obtained in the absence of the inhibitor sample, is determined.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04873253 |
|---|
| Source dataset | uspto-grants-1989_10 |
|---|
| ORD ID | ord-9ef03242ae0d4da18105da159b70036d |
|---|
| Source note | uspto-grants-1989_10 |
|---|